
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.
THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE").
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION
FOR IMMEDIATE RELEASE
24 April 2025
Statement of Intention Not to Make an Offer for Advanced Medical Solutions Group plc
Further to the announcements made on 27 March 2025 by Advanced Medical Solutions Group plc (the "Company" or "AMS") and Montagu Private Equity LLP, in its capacity as adviser to funds managed and/or advised by it or its affiliates ("Montagu"), in relation to a possible offer, Montagu now confirms that it does not intend to make an offer for AMS. As a result, Montagu and any person(s) acting in concert with it will, except with the consent of the Takeover Panel, be bound by the restrictions contained in Rule 2.8 of the Code.
Under Note 2 on Rule 2.8 of the Code, Montagu, and any person(s) acting in concert with it, reserves the right to set the restrictions in Rule 2.8 of the Code aside in the following circumstances:
a) with the agreement of the board of directors of AMS;
b) following the announcement by or on behalf of a third party of a firm intention to make an offer for AMS;
c) if AMS announces a Rule 9 waiver proposal (as described in Note 1 of the Notes on Dispensations from Rule 9 of the Code) or a reverse takeover (as defined in the Code); and
d) if there has been a material change of circumstances (as determined by the Takeover Panel)
Enquiries:
Greenbrook Advisory (PR Adviser to Montagu) | +44 (0) 20 7952 2000 |
James Madsen | Montagu@greenbrookadvisory.com |
| |
| |
Jefferies International Limited (Financial Adviser to Montagu) | +44 (0) 20 7029 8000 |
Philip Noblet | |
Thomas Bective | |
Jee Lee | |
Eleanor McDonald | |
Important notices:
This announcement is not intended to and does not constitute an offer to buy or the solicitation of an offer to subscribe for, sell or otherwise dispose of, or an invitation to purchase or subscribe for any securities or the solicitation of any vote in any jurisdiction whether pursuant to this announcement or otherwise.
A copy of this announcement will be made available at Montagu's website on https://montagu.com/news/ by no later than 12 noon (London time) on 25 April 2024. For the avoidance of doubt, the contents of this website are not incorporated into and do not form part of this announcement.
The release, publication or distribution of this announcement in whole or in part, directly or indirectly, in, into or from jurisdictions outside the United Kingdom may be restricted by law and therefore persons in such jurisdictions or into whose possession this announcement comes should inform themselves about and observe such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.
This announcement has been prepared in accordance with English law and information disclosed may not be the same as that which would have been prepared in accordance with the laws of jurisdictions outside England.
END
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.